Printer Friendly
The Free Library
14,551,645 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Kronos Longevity Research Institute --KLRI-- Announces 5-Year Study on Risks and Benefits of Early Menopausal Hormone Therapy.


Business Editors/Health/Medical Writers

PHOENIX--(BUSINESS WIRE)--Oct. 7, 2003

Kronos Early Estrogen Prevention Study (KEEPS) Will Be a

Randomized ran·dom·ize  
tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es
To make random in arrangement, especially in order to control the variables in an experiment.
, Controlled Trial of 900 Women that Examines

the Effects of Estrogen on the Progression of Atherosclerosis

Kronos Longevity Research Institute (KLRI KLRI Korea Legislation Research Institute ) today announced plans for the Kronos Early Estrogen Prevention Study (KEEPS), a five-year study of female hormone replacement therapy Hormone Replacement Therapy Definition

Hormone replacement therapy (HRT) is the use of synthetic or natural female hormones to make up for the decline or lack of natural hormones produced in a woman's body.
 aimed at providing prospective data on the risks and benefits of early menopausal hormonal intervention, particularly as it relates to the progression of atherosclerosis. Atherosclerosis is a medical condition in which fatty material is deposited along the walls of arteries. This fatty material thickens, hardens and may eventually block arteries and cause heart disease.

The study also will compare conjugated oral with transdermal estrogen treatment to further elucidate the potential role of their differential actions in mediating adverse effects of menopausal hormone therapy (MHT MHT Multiple-Hypothesis Tracking
MHT Male Hose Thread
MHT Mental Health Team
MHT Multiple Hypothesis Testing
MHT Manchester, NH, USA - Manchester (Airport Code)
MHT Multi-server Hyper-threading Transportation
).

"Despite more than 40 years of research, menopausal hormone replacement therapy with estrogen or estrogen/progestin remains one of the most debatable areas in medicine," said Dr. S. Mitchell Harman, director of KLRI. "The controversial Women's Health Initiative Women's Health Initiative A 15-yr, $628 million project involving 1. An observational study of the health habits and medical Hx of ±100,000 ♀ 2.  (WHI WHI Women's Health Initiative
WHI Women's Health Issues (journal)
WHI Women's Health Institute
) study has left many questions unanswered. We have concluded that additional trials of MHT in a target population much younger than the mean age of 62.7 that was studied in the WHI will be required to shed light on the risk-benefit ratio of early MHT."

Prior to the WHI study, most data suggested that hormone replacement therapy was associated with a high degree of protection (40-60 percent reductions) against coronary heart disease coronary heart disease: see coronary artery disease.
coronary heart disease
 or ischemic heart disease

Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis).
, all-cause mortality and osteoporotic fractures, in addition to a small increase in breast cancer risk.

KEEPS DESIGN

The Kronos Early Estrogen Prevention Study will be a randomized, placebo-controlled, double-blinded examination of healthy peri-menopausal women ages 45 to 54. Researchers will recruit 900 study participants at five yet-to-be-determined clinical trial sites. KLRI will serve as the coordinating center, but will not recruit study participants.

For additional media materials or to request an interview, please contact Nick Quan or Stephanie Jarnagan at (602) 956-9934.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 7, 2003
Words:339
Previous Article:Peyton R. Patterson is Recognized by U.S. Banker Magazine Among 'The 25 Most Powerful Women in Banking'.
Next Article:IR Recognition Systems Biometric HandReaders Secure 3,500 Employee North Carolina Hospital.



Related Articles
PRESCRIPTION FOR UNCERTAINTY QUESTIONS, WORRIES PLAGUE WOMEN ON HORMONE REPLACEMENT THERAPY.(U)
Study on menopause raises questions.(Columns)(Column)
Common questions about HRT. (Ask the Expert).
Unproven elixir: hormone therapy tempts aging men, but its risks haven't yet been reckoned.(synthetic testosterone)
Hormone replacement takes more hits. (Flawed Therapy).
The rise and fall of hormone therapy: what began decades ago with promises of eternal youth for women ended last year with troubling research...
NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase.(Special Report)
Women weigh risks, benefits of hormone therapy.(Health)
Managing menopause: hormone therapy & other options.
Common questions about hormone therapy.(Ask the Expert)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles